Potential participants in our trials are carefully screened for both their safety during the study and to ensure that they meet all inclusion, and no exclusion criteria as stated in the protocol. Our physician-investigators perform the consenting and screening of all participants, and do direct patient assessments at every study visit. Participants are referred back to their regular health care provider(s) at the completion of every trial.

All of our participants are requested to sign a HIPAA-compliant authorization for release of their medical records to assist us in verifying their appropriateness for a particular trial. Also, with their written authorization, we may discuss in general terms their participation with their health care provider. At a participant’s request, we may provide them with a copy of laboratory results obtained during the study. However, due to strict confidentiality and disclosure agreements, we are unable to discuss specific protocol and study drug details with participants’ health care providers.

Information about our ongoing trials is available on our Current Studies page.

If you would like to refer a patient as a possible participant for one of our studies, please feel free to share the information available on our website or ask him/her to Contact Us directly. Unfortunately, due to the Privacy Rule, we are no longer able to accept identified patient referrals from providers to our studies, but we give detailed study information to each potential participant, as well as a study-specific consent form that they may take home to consider, before they agree to participate in any of our trials.